Abstract
| Medical management of pediatric inflammatory bowel disease Baldwin KR1, Kaplan JL2. Semin Pediatr Surg. 2017 Dec;26(6):360-366. doi: 10.1053/j.sempedsurg.2017.10.005. Epub 2017 Oct 5. |
| Author information 1 Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA. 2 Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA. Electronic address: jlkaplan@partners.org. Abstract Inflammatory bowel diseases (IBD) are chronic autoimmune conditions of the gut affecting both pediatric and adult patients. Medical therapy is often successful at inducing and maintaining remission and preventing disease complications. The mainstays of treatment are medications and other therapies that reduce inflammation and suppress the overactive immune system. Here we review current medical therapies for pediatric IBD, discuss future therapeutics, and present current treatment goals and approaches. |
© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.
